New developments in therapy for colorectal cancer

被引：6
作者：
Sharlene Gill
Richard M. Goldberg
机构：
[1] Division of Medical Oncology, Mayo Clinic, Rochester, MN 55905
来源：
Current Oncology Reports | 2003年 / 5卷 / 3期
关键词：
Rectal Cancer; Clin Oncol; Irinotecan; Total Mesorectal Excision; Vascular Endothelial Cell Growth Factor;
D O I：
10.1007/s11912-003-0109-4
中图分类号：
学科分类号：
摘要：
Colorectal cancer remains a significant cause of cancer death, and its treatment is the subject of active, ongoing investigation within all treatment modalities, including surgery, chemotherapy, and radiotherapy. In this review we discuss selected interesting and important research findings since the year 2000 and comment on their potential impact on the adjuvant and advanced disease management of patients with colon and rectal cancer. Copyright © 2003 by Current Science Inc.
引用
收藏
页码：183 / 191
页数：8
相关论文
共 48 条
  • [1] Jemal A., Thomas A., Murray T., Thun M., Cancer statistics 2002, CA Cancer J. Clin., 52, pp. 23-47, (2002)
  • [2] Nelson H., Petrelli N., Carlin A., Et al., Guidelines 2000 for colon and rectal cancer surgery, J. Natl. Cancer Inst., 93, pp. 583-596, (2001)
  • [3] Weeks J.C., Nelson H., Gelber S., Et al., Short-term quality-of-life outcomes following laparoscopic-assisted colectomy vs open colectomy for colon cancer: A randomized trial, JAMA, 287, pp. 321-328, (2002)
  • [4] Schrag D., Cramer L.D., Bach P.B., Et al., Influence of hospital procedure volume on outcomes following surgery for colon cancer, JAMA, 284, pp. 3028-3035, (2000)
  • [5] Tepper J.E., O'Connell M.J., Niedzwiecki D., Et al., Impact of number of nodes retrieved on outcome in patients with rectal cancer, J. Clin. Oncol., 19, pp. 157-163, (2001)
  • [6] Stocchi L., Nelson H., Sargent D.J., Et al., Impact of surgical and pathologic variables in rectal cancer: A United States community and cooperative group report, J. Clin. Oncol., 19, pp. 3895-3902, (2001)
  • [7] Hodgson D.C., Fuchs C.S., Ayanian J.Z., Impact of patient and provider characteristics on the treatment and outcomes of colorectal cancer, J. Natl. Cancer Inst., 93, pp. 501-515, (2001)
  • [8] Heald R.J., Moran B.J., Ryall R.D., Et al., Rectal cancer: The Basing-stoke experience of total mesorectal excision, 1978-1997, Arch. Surg., 133, pp. 894-899, (1998)
  • [9] Kapiteijn E., Marijnen C.A., Nagtegaal I.D., Et al., Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer, N. Engl. J. Med., 345, pp. 638-646, (2001)
  • [10] Tepper J.E., O'Connell M., Niedzwiecki D., Et al., Adjuvant therapy in rectal cancer: Analysis of stage, sex, and local control: Final report of Intergroup 0114, J. Clin. Oncol., 20, pp. 1744-1750, (2002)
12345